ThursdayJan 12, 2023 11:30 am

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Inks LOI for First HAPI Café in New York City

Sharing Services Global (OTCQB: SHRG), a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies, has inked a binding letter of intent  (“LOI”) with American Wealth Mining Corporation (OTC: HIPH) to franchise the first HAPI Café location in New York City. SHRG is the master franchisor of HAPI Café in North America. According to the announcement, the companies plan to complete the transaction by the end of this month. In addition to the New York City location, American Wealth Mining anticipates opening 20 more HAPI Cafes in New York state in…

Continue Reading

ThursdayJan 12, 2023 11:15 am

Vision Energy Corp. (VENG) Files Application Initiating Formal Environmental Permit Assessment Process for Green Energy Hub Terminal Development Project in the Netherlands

Vision Energy is pioneering a Green Energy Hub terminal development project for the importation, storage, handling, and distribution of low-carbon renewable fuels and hydrogen carriers, including green ammonia, methanol, and biofuels The company intends to construct the development in phases, with Phase 1 accommodating 400,000 cubic meters of renewable liquid bulk storage and supporting infrastructure Vision Energy has engaged environmental experts and specialist Netherlands-based consultancy firms to undertake detailed studies to support final permit applications for the development Vision Energy (OTCQB: VENG), through its wholly owned subsidiary Evolution Terminals BV, is in the advanced stages of planning the construction of…

Continue Reading

ThursdayJan 12, 2023 11:15 am

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Moves to Acquire MeridianBet Group

Golden Matrix Group (NASDAQ: GMGI) is a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content. The company today announced its entry into a definitive acquisition agreement pursuant to which it has agreed to acquire MeridianBet Group and its related companies in a cash and stock transaction valued at approximately $300 million. MeridianBet is Southeast Europe’s leading business-to-consumer (“B2C”) sports betting and gaming group with headquarters in Malta, operating in multiple markets across Europe, Africa and Latin America. “We are thrilled to announce our entry into a purchase agreement with the shareholders of MeridianBet…

Continue Reading

ThursdayJan 12, 2023 10:50 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Traders News Source Interview

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, was featured in a new C-level interview with Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies. Branislav Vajdic, PhD, CEO and founder of HeartBeam joined Traders News Source’s Toni Loudenbeck to provide an overview of HeartBeam and discuss the potential for the company’s innovative AIMI(TM) and AIMIGo(TM) technology. In the interview, Dr. Vajdic shares his background and vision leading up to the company’s 12-lead standard…

Continue Reading

ThursdayJan 12, 2023 10:33 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(R). The company today announced that it has selected Generalized Anxiety Disorder (“GAD”) with or without major depressive disorder (“MDD”) as the target indication for CYB004 — its proprietary deuterated N, N-dimethyltryptamine (“DMT”) molecule. “Based on preclinical data, CYB004 has shown promise in treating anxiety disorders. About half of people suffering from depression are also burdened with GAD, which makes the need for more effective treatment options for GAD even more urgent,” said Cybin CEO Doug Drysdale. “Since the pandemic, the prevalence of depression and…

Continue Reading

ThursdayJan 12, 2023 10:30 am

SideChannel Inc. (SDCH) – Creating Top-Tier Data and Asset Protection Cybersecurity Programs for Small Businesses, including the Crypto Sector

SideChannel is on a mission to make cybersecurity simple and accessible, mainly targeting small and mid-sized organizations which often fall victim to hackers given their insufficient budgets to invest in an on-site Chief Information Security Officer (“CISO”) With hacking and ransomware attacks on the rise, crypto operations, as well as other small and mid-sized organizations, are at risk of falling victim, resulting in a disruption and potentially damaging their operations While code audits are still essential, SideChannel’s unique approach to the problem (creating top-tier cybersecurity programs) guarantees both asset and data protection for these enterprises Within the first three months…

Continue Reading

ThursdayJan 12, 2023 10:13 am

QualityStocksNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces Approval of Preferred Stock Issue by Shareholders

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, reported that its stockholders approved the company’s proposal to issue 100,000 shares of Series A Convertible Preferred Stock to Koito Manufacturing Co. Ltd.  The issuance, which would be for $100 million, is based on the terms of an investment agreement between the two companies that was signed on Oct. 27, 2022. According to the announcement, the investment should close on Jan. 19, 2023. Shareholders voted on the proposal during Cepton’s recent special meeting of shareholders, which was held on Jan. 11, 2023. To view the full press release,…

Continue Reading

ThursdayJan 12, 2023 9:45 am

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) CEO Talks Importance of a Company’s Approach to Cybersecurity on ‘Shrimp Tank’ Podcast

Cerberus believes successful cybersecurity must be woven into an organization’s fabric, transforming its culture While cybersecurity has become a well-known topic, surprisingly few companies are doing anything about it Every 11 seconds, someone is targeted or hacked, and the weakest link inside a company is people who aren’t prepared, says CISO CEO The idea that “cybersecurity is a culture, not a product” has never been more relevant or profound, says podcast host Ted Jenkin, who chatted with Cerberus Cyber Sentinel (NASDAQ: CISO) CEO David Jemmett during a recent episode of “The Shrimp Tank” (https://ibn.fm/o4CTg). Cerberus has trademarked that phrase and…

Continue Reading

ThursdayJan 12, 2023 9:00 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Positive Update on Ongoing Study into the Use of Joint Homing Peptides as an Alternative Treatment for Rheumatoid Arthritis

Silo Pharma recently provided an update on an ongoing study delving into the potential use of SPU-21 joint homing peptides as an alternative treatment for rheumatoid arthritis The study, which is being carried out in conjunction with the University of Maryland, Baltimore, has resulted in positive initial results Since its founding, Silo Pharma has rapidly gained a reputation for its innovative approach towards seeking solutions to address a variety of underserved medical conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently revealed the positive interim data from its dose optimization…

Continue Reading

WednesdayJan 11, 2023 12:03 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine

Aditxt (NASDAQ: ADTX), a biotech innovation company, is developing and commercializing technologies with a focus on monitoring and modulating, mapping and reprogramming the immune system, designing technologies to provide a personalized immune profile. “In late October 2022, Aditxt announced the creation of its Adimune(TM) program. At the same time, Aditxt announced that Adimune initiated the GMP manufacturing of drug candidate ADI(TM)-100 for purposes of initiating human trials. The trial will be performed in autoimmune diseases, with psoriasis as the first indication to be studied. Adimune’s nucleic acid-based technology, ADI(TM), has shown in preclinical studies the ability to restore/induce immune tolerance…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered